The Oncology Grand Rounds series is designed to place original reports published in the Journal into clinical context. A case presentation is followed by a description of diagnostic and management […]
Recent Content
- Targeting RNA polymerase I to boost natural killer cell anticancer activity in multiple myeloma
- The impact of extramedullary and paraskeletal plasmacytomas on treatment outcomes in multiple myeloma treated with teclistamab: U.S. Myeloma Immunotherapy Consortium real-world experience
- (no title)
- New center promotes advocacy for gynecological cancer patients
- FDA clears Thermo Fisher EXTENT system for myeloma diagnosis
- Microbiome modulation uncouples efficacy and toxicity induced by immune checkpoint blockade in mouse multiple myeloma
- TSCM-predominant allogeneic anti-BCMA CAR-T therapy for relapsed/refractory multiple myeloma: preclinical characterization and interim results from a phase 1 trial
- (no title)
- (no title)
- New ‘powerful’ lab test will help researchers explore blood cancer